Manchester reports vaccine medicines Manchester

Trial of Oxford/AstraZeneca vaccine in children paused amid blood clot concerns

Reading now: 315
manchestereveningnews.co.uk

Don't miss a thing by getting the latest from the Manchester Evening News sent direct to your inbox A trial of the Oxford/AstraZeneca coronavirus vaccine on children has been paused amid concerns over rare blood clots.

Regulators at the Medicines and Healthcare products Regulatory Agency (MHRA) are investigating a potential association between the jab and a rare form of blood clot.

A spokesperson from the university said in a statement: “Whilst there are no safety concerns in the paediatric clinical trial, we await additional information from the MHRA on its review of rare cases of thrombosis/thrombocytopaenia that have been reported in adults, before giving any further vaccinations in the trial. “Parents and children should continue to

Read more on manchestereveningnews.co.uk
The website starsalert.com is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA